z-logo
Premium
Structure conservation in cytochromes P450
Author(s) -
Mestres Jordi
Publication year - 2004
Publication title -
proteins: structure, function, and bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.699
H-Index - 191
eISSN - 1097-0134
pISSN - 0887-3585
DOI - 10.1002/prot.20354
Subject(s) - sequence (biology) , multiple sequence alignment , computational biology , cytochrome p450 , protein structure , sequence alignment , stereochemistry , chemistry , biology , biochemistry , peptide sequence , enzyme , gene
The recent availability of crystal structures for several diverse cytochromes P450 (CYPs) offers the possibility to perform an up‐to‐date comparative analysis to identify the degree of structure conservation among this superfamily of enzymes specially relevant for their involvement in drug metabolism and toxicity. A set of 9 CYPs sharing between 10% and 27% sequence identity was selected, including 7 class I (CYP 101, 107, 108, 119, 121, 51, and 55) and two class II (CYP 102, and 2C5) structures. After obtaining a multiprotein structure superimposition, a structure‐based sequence alignment was derived. Mapping the level of three‐dimensional structural conservation onto the sequence alignment revealed that over 28% of the alignment positions have the C α carbons of their residues within a root‐mean‐square deviation (RMSD) of 2 Å. This degree of structure conservation is found to be generally preserved, even when the structure undergoes dramatic conformational changes. Performing the analysis on 4 members of the CYP2 family (CYP 2B4, 2C5, 2C8, and 2C9), the percentage of alignment positions within 2 Å RMSD amounted to 73%, increasing to over 85% when only structures in a closed conformation are considered. The present findings suggest that it should be plausible to derive models of overall good quality for the major CYP2 metabolizing forms (CYP 2A6, 2C19, 2D6, and 2E1), whereas high levels of uncertainty are still likely to be expected in models for the remaining 2 major P450 metabolizing forms (CYP 1A2 and 3A4), with the corresponding implications for their potential applicability in drug design activities. Proteins 2005. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here